Treatment of bladder cancer

Written by Wang Jian
Urology
Updated on September 11, 2024
00:00
00:00

For the treatment of bladder cancer, it is necessary first to confirm the diagnosis of bladder cancer through routine urine tests, ultrasonographic examination of the urinary system, cystoscopy, and imaging studies of the urinary system. It is important to determine the location, area, and malignancy of the bladder tumor. For early-stage superficial bladder tumors or tumors on the bladder wall with fewer numbers, minimally invasive surgery can be performed, followed by bladder perfusion to prevent recurrence of the bladder tumor. In the second scenario, if the bladder tumor is multiple and larger, and has a higher degree of malignancy in the bladder trigone area, then a radical cystectomy is required. Radical cystectomy involves the removal of the bladder along with the prostate in males or the uterus in females, followed by the creation of a urinary diversion, typically through these two treatment methods.

Other Voices

doctor image
home-news-image
Written by Liu Liang
Oncology
40sec home-news-image

What are the symptoms of bladder cancer?

Bladder cancer's most common symptom is a consistent presence of painless gross hematuria. Some patients also exhibit frequent urination, urgency, and pain during urination as initial signs of bladder irritation. In advanced local stages, palpable pelvic tumors can be detected in patients, with symptoms such as urinary retention, lower abdominal pain, and inability to urinate. In the late stages of bladder cancer, patients may experience weight loss, back and flank pain, and signs of renal failure among other clinical manifestations.

doctor image
home-news-image
Written by Wang Jian
Urology
49sec home-news-image

Is bladder cancer hereditary?

Bladder cancer is the most common malignant tumor in urology, occurring on the mucosa of the bladder and is also one of the top ten common tumors globally. The etiology of bladder cancer is complex, involving both intrinsic genetic factors and external environmental factors, which gives bladder cancer a hereditary tendency. Notable among the major risk factors are smoking and occupational exposure to aromatic amines, with 30% to 50% of bladder cancers caused by smoking. The incidence of bladder cancer significantly increases with the duration of smoking. The initial clinical manifestation of bladder cancer is usually hematuria, typically painless and intermittent gross hematuria. The presence of blood in urine should prompt further diagnostic testing to rule out malignant tumors in the bladder.

doctor image
home-news-image
Written by Xu Chun Hua
Urology
39sec home-news-image

Early symptoms of bladder cancer

Hematuria is the most common and earliest symptom of bladder cancer, with 85% of patients experiencing intermittent gross hematuria which can decrease or stop on its own, often giving patients a false impression of improvement or cure, thus delaying treatment. Sometimes, hematuria is also found under a microscope, and the amount of bleeding is not necessarily consistent with the size, number, or malignancy of the tumor. The hematuria from bladder tumors can initially be mild, and other symptoms such as frequent urination, urgency, and painful urination may also occur; these are all manifestations of bladder tumors.

doctor image
home-news-image
Written by Zou De Bo
Urology
29sec home-news-image

How to prevent bladder cancer

Bladder cancer is one of the most common malignant tumors in the urinary system. Currently, the exact cause of bladder cancer is not clear. In terms of prevention, it is generally necessary to drink more water, urinate more frequently, try not to smoke, and reduce exposure to chemical irritants, such as paint, chemical substances, etc. Additionally, an annual physical examination is recommended to enable early detection and early treatment.

doctor image
home-news-image
Written by Liu Liang
Oncology
30sec home-news-image

What medicine is infused into the bladder for bladder cancer?

Postoperative intravesical chemotherapy infusion is very common in the treatment of bladder cancer. Common drugs used for infusion chemotherapy include mitomycin and anthracyclines such as epirubicin or pirarubicin. Gemcitabine is also frequently used for this purpose. The related side effects generally include irritation symptoms of the bladder, although some patients may experience relatively mild side effects.